METRONOMIC CAPECITABINE AS SALVAGE CHEMOTHERAPY IN PRETREATED PATIENTS WITH ADVANCED GASTROINTESTINAL CANCER (AGIC)

被引：0
|
作者：
Barucca, V
Romiti, A.
Sarcina, I
Di Rocco, R.
Morelli, F.
Durante, V
Marchetti, P.
机构：
[1] Univ Roma La Sapienza, St Andrea Hosp, Rome, Italy
[2] IDI IRCS, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [31] Rationale for the use of metronomic chemotherapy in gastrointestinal cancer
    Filippi, Roberto
    Lombardi, Pasquale
    Depetris, Ilaria
    Fenocchio, Elisabetta
    Quara, Virginia
    Chila, Giovanna
    Aglietta, Massimo
    Leone, Francesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (13) : 1451 - 1463
  • [32] Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours
    Roberto, M.
    Arrivi, G.
    Milano, A.
    D'Antonio, C.
    Romiti, A.
    Falcone, R.
    Mazzuca, F.
    Fais, S.
    Marchetti, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Metronomic schedule of capecitabine in poor performance status patients with pretreated solid tumors
    Amadio, P.
    Mattina, M.
    Lavenia, G.
    Rampello, E.
    Caputo, G.
    Sambataro, D.
    Salice, P.
    Latteri, F.
    Parra, E. S.
    Cordio, S.
    ANNALS OF ONCOLOGY, 2006, 17 : XI35 - XI36
  • [34] Neoadjuvant chemotherapy with metronomic doxorubicin, cyclophosphamide, and capecitabine in patients with locally advanced (LA) triple-negative breast cancer (TNBC)
    Frolova, Mona
    Skrypnikova, Marina
    Ignatova, Ekaterina
    Petrovsky, Alexander
    Stenina, Marina
    Ivankina, Oxana
    Vishnevskaja, Yana
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] DOCETAXEL-CARBOPLATIN FOR PATIENTS WITH ADVANCED PANCREATIC CANCER PROGRESSING AFTER GEMCITABINE-BASED CHEMOTHERAPY FOLLOWED BY METRONOMIC CAPECITABINE
    Shaltout, Ehab
    Abd El Razek, Eman
    El-Gamal, Ahmed
    ANNALS OF ONCOLOGY, 2012, 23 : 62 - 62
  • [36] PANITUMUMAB PLUS CHEMOTHERAPY AS SALVAGE TREATMENT IN PRETREATED ADVANCED COLORECTAL CANCER PATIENTS: A SINGLE INSTITUTION'S EXPERIENCE
    Giuliani, F.
    Cito, P.
    Porcelli, M.
    Misino, A.
    Latorre, A.
    Silvestris, N.
    Guida, M.
    Galetta, D.
    Palermo, L.
    Gentile, M.
    Colucci, G.
    CANCER TREATMENT REVIEWS, 2010, 36 : S96 - S96
  • [37] Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
    Dellapasqua, Silvia
    Bertolini, Francesco
    Bagnardi, Vincenzo
    Campagnoli, Elisabetta
    Scarano, Eloise
    Torrisi, Rosalba
    Shaked, Yuval
    Mancuso, Patrizia
    Goldhirsch, Aron
    Rocca, Andrea
    Pietri, Elisabetta
    Colleoni, Marco
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4899 - 4905
  • [38] 5-Fluorouracil Degradation Rate in Patients with Recurrent Gastrointestinal Cancer Treated with Metronomic Capecitabine
    Roberto, M.
    Romiti, A.
    Lionetto, L.
    D'Antonio, C.
    Onesti, C.
    Botticelli, A.
    Milano, A.
    Falcone, R.
    Occhipinti, M.
    Mazzuca, F.
    Simmaco, M.
    Marchetti, P.
    ANNALS OF ONCOLOGY, 2016, 27 : 12 - 12
  • [39] Metronomic chemotherapy option for advanced oral cancer
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2019, 20 (11): : E614 - E614
  • [40] Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients
    Paloma Valenzuela
    Derrick Oaxaca
    Teresa Di Desidero
    Karla Parra
    Georgialina Rodriguez
    Marian Manciu
    Giacomo Allegrini
    Alfredo Falcone
    Guido Bocci
    Robert A. Kirken
    Giulio Francia
    Clinical and Experimental Medicine, 2021, 21 : 149 - 159
12345